CPT code 92230 represents fluorescein angiography of the retina and/or choroid with interpretation and report, a diagnostic imaging service that uses injectable dye to visualize ocular vasculature. This procedure is commonly used for evaluation of macular disease, retinal vascular conditions, inflammatory retinal or choroidal disease, optic nerve disorders, tumors, and to plan laser treatments. Nationally, 92230 is important for retina specialists and general ophthalmologists because it supports diagnostic decision-making for sight-threatening conditions and documents findings for treatment planning.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical indications and service context, payer coverage considerations and typical site-of-service expectations, and common billing considerations such as service line placement. The publication also summarizes available benchmarks and policy updates where present and highlights clinical contexts in which the study is most frequently used. Data not available in the input will be noted as such.